Last checked at 26 Jun 2017 07:00
Animalcare Group Plc
("Animalcare" or the "Company")
Restoration of Ordinary Shares to trading on AIM
Further to the Company's announcements released on 23 June 2017 regarding the proposed acquisition of Ecuphar NV, the Company announces that an Admission Document including a circular and a notice of general meeting has been published and posted to Shareholders. The Admission Document is available to view on the Company's website at:
www.animalcaregroup.co.uk/investors/constitutional-documents/aim-admission-document
Accordingly, trading in the Company's Ordinary Shares on AIM will resume from 8.00 a.m. on 26 June 2017.
Enquiries:
| |||||||||||||||||||||||||||||||||||||||||||
About Animalcare
Animalcare is a leading veterinary sales and marketing company based in York with 67 employees including a sales team of 22 selling to veterinary practices around the United Kingdom.
Animalcare has developed a range of generic veterinary medicines and animal identification products primarily to companion animal veterinary markets.
Animalcare operates in three product areas:
· Licensed Veterinary Medicines
· Animal Welfare Products
· Companion Animal Identification
For more information see: www.animalcaregroup.co.uk